Rossmax International Ltd. (TPEX:4121)

Market Cap	1.28B
Revenue (ttm)	3.85B
Net Income (ttm)	-41.02M
Shares Out	84.75M
EPS (ttm)	-0.50
PE Ratio	n/a
Forward PE	n/a
Dividend	0.50 (3.32%)
Ex-Dividend Date	Jun 12, 2024

Volume	61,082
Average Volume	158,099
Open	14.95
Previous Close	15.05
Day's Range	14.95 - 15.00
52-Week Range	11.65 - 21.70
Beta	0.49
RSI	57.59
Earnings Date	Aug 8, 2025

About Rossmax International

Rossmax International Ltd. develops and supplies healthcare products and solutions. The company offers body fat monitors and scales that are used to measure body fat, body mass index, lean mass, muscle mass, and water ratio along with body weight; blood pressure monitors; sphygmomanometer, a device that measures blood pressure; stethoscope, an acoustic medical device for auscultation, or listening to the internal sounds of an animal or human body; handheld pulse oximeter monitors to measure the amount of oxygen carried in the body; non-contact ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1988
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4121

Financial Performance

In 2024, Rossmax International's revenue was 3.85 billion, an increase of 1.11% compared to the previous year's 3.81 billion. Losses were -29.35 million, 340.3% more than in 2023.